I'm an entrepreneurial DPhil student at the University of Oxford developing novel approaches to treat rare neurological disorders under the supervision of Prof. Jenny Taylor, Prof. Carlo Rinaldi, and Dr. Carme Camps. I'm fortunate to be fully-funded by a Clarendon Scholarship for academic merit and St John's College.
Before starting my DPhil, I worked as a commercial analyst at some of the UK's fastest-growing healthcare companies and have a long-standing interest in digital healthcare tools, advanced therapeutics, and improving healthspan.
Education
-
DPhil in Clinical Medicine — University of OxfordAug 2025 – presentClarendon Scholar
-
MSc Genomic Medicine — University of OxfordOct 2023 – Sept 2024Distinction
-
BSc Molecular Biology — Durham UniversityOct 2020 – July 2023First-Class Honours · Top 10% of cohort every year
Experience
-
Activator Lead — Nucleate, OxfordJan 2026 – presentLead an accelerator programme for biotech spin-outs from top UK academic institutions. Programme alumni have collectively raised over $600M since 2019. In my first three months, I have: organised two workshops, led three panel discussions with senior policy and biotech researchers, and recruited over 20 expert mentors and speakers to support our 2026 cohort.
-
Business Analyst — Genomics Ltd., LondonFeb 2025 – July 2025Contributed to commercial strategy initiatives including pitch decks and comms documents for a polygenic risk test, supporting successful deals with two of America's largest life insurers and the UK's top three private health providers. Analysed 400+ biotech pipelines to build a ranked outreach list. Contributed to board materials and presented strategic insights to the C-suite.
-
Business Analyst — Complement Therapeutics, LondonSummer 2023Supported IND-enabling activities for CTx001 (now a clinical-stage AAV gene therapy for dry age-related macular degeneration), including US patient recruitment and commercial due diligence. Produced a 100+ slide competitive intelligence document for the annual board meeting.
-
Globalink Research Scholar — University of British Columbia, VancouverSummer 2022Developed novel lipid-based delivery systems for nucleic acids with potential applications in gene therapy and gene editing.
Projects
-
AiM Therapeutics2023Co-designed an RNAi-based vaccination technology for honeybees. Held conversations with KOLs, developed a five-year business and R&D plan, and won a university-wide pitching competition.
Awards & Extracurricular
-
Clarendon Scholarship2025Awarded annually to Oxford students for academic excellence and future potential (worth $130,000+).
-
GlobalLink Scholarship2022Selected from 9,000+ students globally to complete research at a leading Canadian university (worth $30,000+).
-
Elite Sport — Rowing2023-2026Represented Oxford University Boat Club at national and international rowing events.